CSNV Fundamental Analysis - AXA NV25

Fundamental Rating

Taking everything into account, CSNV scores 4 out of 10 in our fundamental rating. CSNV was compared to 43 industry peers in the Insurance industry. CSNV has an average financial health and profitability rating. CSNV is not valued too expensively and it also shows a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CSNV was profitable.

CSNV had a positive operating cash flow in the past year.

Each year in the past 5 years CSNV has been profitable.

CSNV had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

CSNV has a Return On Assets (1.09%) which is in line with its industry peers.

CSNV has a Return On Equity (14.13%) which is in line with its industry peers.

With a Return On Invested Capital value of 1.21%, CSNV perfoms like the industry average, outperforming 47.22% of the companies in the same industry.

The Average Return On Invested Capital over the past 3 years for CSNV is in line with the industry average of 2.26%.

		Industry Rank	Sector Rank
ROA	1.09%
ROE	14.13%
ROIC	1.21%

ROA(3y)1.01%

ROA(5y)0.77%

ROE(3y)12.73%

ROE(5y)9.51%

ROIC(3y)1.23%

ROIC(5y)1.01%

1.3 Margins

The Profit Margin of CSNV (8.23%) is comparable to the rest of the industry.

CSNV's Profit Margin has improved in the last couple of years.

With a Operating Margin value of 11.15%, CSNV perfoms like the industry average, outperforming 44.44% of the companies in the same industry.

CSNV's Operating Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	11.15%
PM (TTM)	8.23%
GM	N/A

OM growth 3Y23.76%

OM growth 5Y4.76%

PM growth 3Y46.22%

PM growth 5Y36.38%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CSNV is destroying value.

Compared to 1 year ago, CSNV has more shares outstanding

Compared to 5 years ago, CSNV has less shares outstanding

The debt/assets ratio for CSNV is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.34, we must say that CSNV is in the distress zone and has some risk of bankruptcy.

CSNV has a better Altman-Z score (0.34) than 83.33% of its industry peers.

The Debt to FCF ratio of CSNV is 3.74, which is a good value as it means it would take CSNV, 3.74 years of fcf income to pay off all of its debts.

Looking at the Debt to FCF ratio, with a value of 3.74, CSNV is in line with its industry, outperforming 44.44% of the companies in the same industry.

CSNV has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.

The Debt to Equity ratio of CSNV (0.49) is better than 72.22% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.49
Debt/FCF	3.74
Altman-Z	0.34

ROIC/WACC0.12

WACC10.29%

2.3 Liquidity

A Current Ratio of 0.99 indicates that CSNV may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.99, CSNV belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.

A Quick Ratio of 0.99 indicates that CSNV may have some problems paying its short term obligations.

CSNV has a Quick ratio of 0.99. This is amongst the best in the industry. CSNV outperforms 88.89% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.99
Quick Ratio	0.99

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CSNV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.27%, which is quite good.

CSNV shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.03% yearly.

CSNV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.52%.

The Revenue has been decreasing by -4.60% on average over the past years.

EPS 1Y (TTM)15.27%

EPS 3Y35.79%

EPS 5Y32.03%

EPS Q2Q%34.3%

Revenue 1Y (TTM)-15.52%

Revenue growth 3Y-9.14%

Revenue growth 5Y-4.6%

Sales Q2Q%-23.49%

3.2 Future

CSNV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.58% yearly.

Based on estimates for the next years, CSNV will show a small growth in Revenue. The Revenue will grow by 0.89% on average per year.

EPS Next Y6.5%

EPS Next 2Y7.56%

EPS Next 3Y10.07%

EPS Next 5Y6.58%

Revenue Next Year-2.14%

Revenue Next 2Y1.08%

Revenue Next 3Y0.89%

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.82, the valuation of CSNV can be described as correct.

Compared to the rest of the industry, the Price/Earnings ratio of CSNV indicates a somewhat cheap valuation: CSNV is cheaper than 66.67% of the companies listed in the same industry.

CSNV is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.

Based on the Price/Forward Earnings ratio of 11.05, the valuation of CSNV can be described as reasonable.

CSNV's Price/Forward Earnings ratio is in line with the industry average.

CSNV is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	12.82
Fwd PE	11.05

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as CSNV.

		Industry Rank	Sector Rank
P/FCF	13.6
EV/EBITDA	N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CSNV does not grow enough to justify the current Price/Earnings ratio.

PEG (NY)1.97

PEG (5Y)0.4

EPS Next 2Y7.56%

EPS Next 3Y10.07%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CSNV does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AXA NV25

EPA:CSNV (5/2/2025, 7:00:00 PM)

+0.8 (+2.04%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupInsurance

GICS IndustryInsurance

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap89.05B

Analysts84.14

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP56.37%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	12.82
Fwd PE	11.05
P/S	1.05
P/FCF	13.6
P/OCF	12.76
P/B	1.8
P/tB	3.29
EV/EBITDA	N/A

EPS(TTM)3.12

EY7.8%

EPS(NY)3.62

Fwd EY9.05%

FCF(TTM)2.94

FCFY7.35%

OCF(TTM)3.13

OCFY7.83%

SpS38.23

BVpS22.27

TBVpS12.17

PEG (NY)1.97

PEG (5Y)0.4

Profitability

		Industry Rank	Sector Rank
ROA	1.09%
ROE	14.13%
ROCE	1.5%
ROIC	1.21%
ROICexc	1.26%
ROICexgc	1.65%
OM	11.15%
PM (TTM)	8.23%
GM	N/A
FCFM	7.69%

ROA(3y)1.01%

ROA(5y)0.77%

ROE(3y)12.73%

ROE(5y)9.51%

ROIC(3y)1.23%

ROIC(5y)1.01%

ROICexc(3y)1.28%

ROICexc(5y)1.05%

ROICexgc(3y)1.64%

ROICexgc(5y)1.33%

ROCE(3y)1.52%

ROCE(5y)1.25%

ROICexcg growth 3Y24.61%

ROICexcg growth 5Y6.97%

ROICexc growth 3Y21.16%

ROICexc growth 5Y7.2%

OM growth 3Y23.76%

OM growth 5Y4.76%

PM growth 3Y46.22%

PM growth 5Y36.38%

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0.13

Health

		Industry Rank	Sector Rank
Debt/Equity	0.49
Debt/FCF	3.74
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	0.5%
Interest Coverage	1.69
Cash Conversion	N/A
Profit Quality	93.5%
Current Ratio	0.99
Quick Ratio	0.99
Altman-Z	0.34

F-Score6

WACC10.29%

ROIC/WACC0.12

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)0.37%

Cap/Sales(5y)0.36%

Profit Quality(3y)112.32%

Profit Quality(5y)257.76%

High Growth Momentum

Growth

EPS 1Y (TTM)15.27%

EPS 3Y35.79%

EPS 5Y32.03%

EPS Q2Q%34.3%

EPS Next Y6.5%

EPS Next 2Y7.56%

EPS Next 3Y10.07%

EPS Next 5Y6.58%

Revenue 1Y (TTM)-15.52%

Revenue growth 3Y-9.14%

Revenue growth 5Y-4.6%

Sales Q2Q%-23.49%

Revenue Next Year-2.14%

Revenue Next 2Y1.08%

Revenue Next 3Y0.89%

Revenue Next 5YN/A

EBIT growth 1Y-4%

EBIT growth 3Y12.44%

EBIT growth 5Y-0.05%

EBIT Next Year19.13%

EBIT Next 3Y10.06%

EBIT Next 5YN/A

FCF growth 1Y-6.97%

FCF growth 3Y-33.47%

FCF growth 5Y-1.8%

OCF growth 1Y-5.64%

OCF growth 3Y-32.45%

OCF growth 5Y-1.79%

AXA NV25 (CSNV.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens